IBB ETF
iShares Biotechnology ETF
IBB ETF Overview
IBB ETF (iShares Biotechnology ETF) is managed by iShares by BlackRock (US) with $10.64B in net assets. IBB expense ratio is 0.44%, holding 253 positions across sectors including Health Care, Information Technology, Industrials. Inception date: 2001-02-05.
IBB performance shows a YTD return of 10.58%. The 1-year return is 40.81% and the 5-year return is 2.65%. IBB dividend yield stands at 0.20%, paid quarterly.
IBB top holdings include Amgen Inc. (8.4%), Nvaesrtex Pharmaceuticals Inc (8.1%), Gilead Sciences Inc (7.2%), Regeneron Pharmaceuticals, Inc. (5.7%), Argenx Se Sponsored Adr (1 Ads : 1 Ordinary) (3.8%). Go to all IBB holdings, IBB sectors, or IBB dividends.
IBB can be compared against other funds. Use IBB overlap to find shared positions, or IBB vs another fund for a side-by-side view. IBB alternatives are available via the screener, along with tax-loss harvesting opportunities.